Nature Communications (Feb 2024)

Multigenerational paternal obesity enhances the susceptibility to male subfertility in offspring via Wt1 N6-methyladenosine modification

  • Yong-Wei Xiong,
  • Hua-Long Zhu,
  • Jin Zhang,
  • Hao Geng,
  • Lu-Lu Tan,
  • Xin-Mei Zheng,
  • Hao Li,
  • Long-Long Fan,
  • Xin-Run Wang,
  • Xu-Dong Zhang,
  • Kai-Wen Wang,
  • Wei Chang,
  • Yu-Feng Zhang,
  • Zhi Yuan,
  • Zong-Liu Duan,
  • Yun-Xia Cao,
  • Xiao-Jin He,
  • De-Xiang Xu,
  • Hua Wang

DOI
https://doi.org/10.1038/s41467-024-45675-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 20

Abstract

Read online

Abstract There is strong evidence that obesity is a risk factor for poor semen quality. However, the effects of multigenerational paternal obesity on the susceptibility to cadmium (a reproductive toxicant)-induced spermatogenesis disorders in offspring remain unknown. Here, we show that, in mice, spermatogenesis and retinoic acid levels become progressively lower as the number of generations exposed to a high-fat diet increase. Furthermore, exposing several generations of mice to a high fat diet results in a decrease in the expression of Wt1, a transcription factor upstream of the enzymes that synthesize retinoic acid. These effects can be rescued by injecting adeno-associated virus 9-Wt1 into the mouse testes of the offspring. Additionally, multigenerational paternal high-fat diet progressively increases METTL3 and Wt1 N6-methyladenosine levels in the testes of offspring mice. Mechanistically, treating the fathers with STM2457, a METTL3 inhibitor, restores obesity-reduced sperm count, and decreases Wt1 N6-methyladenosine level in the mouse testes of the offspring. A case-controlled study shows that human donors who are overweight or obese exhibit elevated N6-methyladenosine levels in sperm and decreased sperm concentration. Collectively, these results indicate that multigenerational paternal obesity enhances the susceptibility of the offspring to spermatogenesis disorders by increasing METTL3-mediated Wt1 N6-methyladenosine modification.